Form 4: Health Catalyst CEO Reports Stock Transaction
Insider Transaction (Form 4)
Benjamin Albert, CEO and a Director of Health Catalyst, Inc., reported a transaction in 35,244 shares of common stock on September 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 35,244 Common Stock at $1.67 ($59,023) on September 10, 2026; holds 1,388,406 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Benjamin Albert — Director, Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tax/exercise-price withholding | Common Stock | 35,244 | $2 | $59.0K | 1,388,406 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Tax/exercise-price withholding (35,244 shares) |
Keywords
insider transaction, Form 4, HCAT, Health Catalyst, Inc., neutral, Benjamin Albert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.